Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Orpha-Devel Handels und Vertriebs GmbH, Wintergasse 85/1B, A-3002, Purkersdorf, Austria
Adepend 50 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. Capsule shaped, beige film-coated tablets with a break-score on each side. The tablet can be divided into equal doses. |
Each film-coated tablet contains 50 mg naltrexone hydrochloride.
Excipients with known effect: contains 126,755 mg lactose monohydrate. For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Naltrexone |
Naltrexone is an orally used, long acting specific opioid antagonist. Naltrexone binds competitively to receptors which are located in the central and peripheral nervous system and hence blocks the access for exogenously administered opioids. |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Film-coat: Lactose monohydrate |
7, 10, 14, 28, 30 or 100 tablets in PVC/PVDC/Aluminium blister packed in a carton.
Not all pack sizes may be marketed.
Orpha-Devel Handels und Vertriebs GmbH, Wintergasse 85/1B, A-3002, Purkersdorf, Austria
PL 30414/0013
22/12/2011 / 08/05/2015
| Drug | Countries | |
|---|---|---|
| ADEPEND | Estonia, Croatia, Lithuania, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
